Clinical Trials on Progressive Myoclonic Epilepsy
Total 3494 results
-
Aristotle University Of ThessalonikiRecruitingFocal EpilepsyGreece
-
Eindhoven University of TechnologyClinical Trial Center Maastricht B.V.RecruitingFocal EpilepsyNetherlands
-
University Hospital, ToursRecruiting
-
Mid-Atlantic Epilepsy and Sleep Center, LLCRecruitingFocal EpilepsyUnited States
-
Xenon Pharmaceuticals Inc.Novotech Health Holdings Pte. Ltd.Active, not recruitingFocal EpilepsySpain, United States, Ukraine, Canada, United Kingdom, Germany, Georgia, Italy, Moldova, Republic of
-
Dhaka Medical CollegeEnrolling by invitationFocal EpilepsyBangladesh
-
Yang XinweiActive, not recruiting
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
Rennes University HospitalCompleted
-
GlaxoSmithKlineWithdrawn
-
Supernus Pharmaceuticals, Inc.CompletedSafety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial EpilepsyPartial EpilepsyUnited States, Poland, Bulgaria, Romania, Canada, Russian Federation, Mexico, Croatia
-
Pavel KleinH. Lundbeck A/SUnknown
-
Central Hospital, Nancy, FranceInstitut National de la Santé Et de la Recherche Médicale, France; CHU de Reims and other collaboratorsCompletedPartial EpilepsyFrance
-
Eisai Inc.CompletedEpilepsyAustralia, France, Poland, Germany, Spain, India, Serbia, Greece, Korea, Republic of, Russian Federation, Taiwan, Hungary, Italy, Sweden, Denmark, Slovakia, United Kingdom, South Africa
-
Mayo ClinicCompleted
-
Cyberonics, Inc.TerminatedEpilepsy | Partial EpilepsyCanada, Spain, Belgium, France, Germany, Italy, Netherlands, Norway, Sweden, United Kingdom
-
Vertex Pharmaceuticals IncorporatedCompletedPartial EpilepsyUnited States
-
University Hospital, Strasbourg, FranceUnknown
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
Hoffmann-La RocheActive, not recruitingProgressive Multiple Sclerosis (PMS)United States, Canada, Brazil, France, Netherlands, Ireland, Germany, Italy, Poland, Russian Federation, Spain, Colombia, Morocco, Hungary, Denmark, Lebanon, Mexico, Costa Rica, Bosnia and Herzegovina, Czechia, Egypt, Guatemala, Panama and more
-
Rigshospitalet, DenmarkDanish Research Centre for Magnetic ResonanceUnknownMultiple Sclerosis (Primary or Secondary Progressive Phase).Denmark
-
University of Alabama at BirminghamRecruitingEpilepsy, Generalized | Memory ImpairmentUnited States
-
InSightecFood and Drug Administration (FDA)Recruiting
-
Mayo ClinicNational Institute of Neurological Disorders and Stroke (NINDS); MedtronicActive, not recruitingEpilepsyUnited States
-
Vertex Pharmaceuticals IncorporatedTerminatedEpilepsyUnited States, Germany
-
Seoul National University HospitalDongsan Medical Center; Konkuk UniversityCompleted
-
Hospices Civils de LyonUnknown
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
Mid-Atlantic Epilepsy and Sleep Center, LLCEisai Inc.TerminatedEpilepsyUnited States
-
Lawson Health Research InstituteUCB Pharma GmbHTerminated
-
Bial - Portela C S.A.Completed
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
Tianjin Eye HospitalRecruitingMyopic ProgressionChina
-
The Hong Kong Polytechnic UniversityMenicon Co., Ltd.Active, not recruitingMyopic ProgressionHong Kong
-
National Taiwan University HospitalNot yet recruiting
-
Wayne State UniversityNational Institutes of Health (NIH)RecruitingFocal EpilepsyUnited States
-
University Hospital, ToulouseRecruiting
-
National Institute of Neurological Disorders and...Recruiting
-
UCB PharmaCompleted
-
University Hospital, ToulouseCerCo, CNRS Cerco UMR5549 CHU Purpan Toulouse France; DIXI Medical, Besançon...Completed
-
H. Lundbeck A/STerminatedFocal EpilepsyUnited States
-
Eisai Korea Inc.Completed
-
NYU Langone HealthThe Epilepsy Study ConsortiumCompleted
-
Korea UCB Co., Ltd.Completed
-
Bial - Portela C S.A.Completed
-
UCB PharmaCompleted
-
UCB PharmaCompleted
-
UCB PharmaCompleted
-
Johannes Gutenberg University MainzUCB Pharma GmbHCompleted